CG Oncology, Inc. Common stock

CGON · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$257,068$8,266$88,143$53,607
Short-Term Investments$484,930$179,408$55,338$0
Receivables$781$92$303$2
Inventory$0$0$0$0
Other Curr. Assets$11,431$6,358$3,424$4,798
Total Curr. Assets$754,210$194,124$147,208$58,407
Property Plant & Equip (Net)$493$491$506$200
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$94$4,686$33$85
Total NC Assets$587$5,177$539$285
Other Assets$0$0$0$0
Total Assets$754,797$199,301$147,747$58,692
Liabilities
Payables$6,517$3,242$985$1,003
Short-Term Debt$186$786$9,155$3,015
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$14,665$10,226$5,289$1,957
Total Curr. Liab.$21,368$14,254$15,429$5,975
LT Debt$52$244$6,789$12,114
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$13$352$351
Total NC Liab.$52$257$7,141$12,465
Other Liabilities$0$0$0$0
Cap. Leases$238$461$446$122
Total Liabilities$21,420$14,511$22,570$18,440
Equity
Pref Stock$0$307,890$202,870$82,870
Common Stock$8$0$0$0
Retained Earnings-$217,981-$129,942-$81,335-$45,892
AOCI$0$0$0$0
Other Equity$951,350$6,842$3,642$3,274
Total Equity$733,377$184,790$125,177$40,252
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$754,797$199,301$147,747$58,692
Net Debt-$256,830-$7,236-$72,199-$38,478